Therefore, it is plausible that inhibition of IL6/ STAT3 pathway by elevated S100B in melanoma cells could be beneficial to early stage tumors as a way to prevent anti-proliferative effects of IL6 and to avoid immune-related destruction. The gene discussed is IL6; the disease is melanoma.